Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation.

Abstract

Authors

• Aditya V Karhade
  Computational Neurosciences Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
• Quirina C B S Thio
  Q. C. B. S. Thio, A. V. Karhade, P. T. Ogink, K. Raskin, S. Lozano-Calderon, J. H. Schwab, Division of Orthopaedic Oncology, Department of Orthopaedics, Massachusetts General Hospital-Harvard Medical School, Boston, MA, USA K. de Amorim Bernstein, Department of Radiation Oncology, Massachusetts General Hospital-Harvard Medical School, Boston, MA, USA.
• Paul T Ogink
• Christopher M Bono
  1Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
• Marco L Ferrone
  Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
• Kevin S Oh
  Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
• Philip J Saylor
  Department of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
• Andrew J Schoenfeld
  Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• John H Shin
  2Department of Neurosurgery, Harvard Medical School, Cambridge, Massachusetts.
• Mitchel B Harris
  Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA.
• Joseph H Schwab
  Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: jhschwab@mgh.harvard.edu.

Keywords

External Resources